{"id":26226,"date":"2017-03-15T01:14:00","date_gmt":"2017-03-15T05:14:00","guid":{"rendered":"https:\/\/www.cancerresearch.org\/blog\/marzo-2017\/michael-r"},"modified":"2022-10-14T16:40:38","modified_gmt":"2022-10-14T20:40:38","slug":"michael-r","status":"publish","type":"post","link":"https:\/\/www.cancerresearch.org\/es\/blog\/michael-r","title":{"rendered":"Michael R&#8217;s Immunotherapy Story"},"content":{"rendered":"\n<p><strong>Linfoma\u00a0| 2008<\/strong><\/p>\n\n\n\n<blockquote class=\"wp-block-quote is-layout-flow wp-block-quote-is-layout-flow\"><p>Algunas de las cosas que hicimos en los \u00faltimos cuatro a\u00f1os, creo que posiblemente nunca hubiera considerado hacerlas de no haber pasado por todo esto.<\/p><\/blockquote>\n\n\n\n<h2 class=\"wp-block-heading\">La historia de Michael<\/h2>\n\n\n\n<p>En 2008 a Michael Rose le diagnosticaron linfoma difuso de c\u00e9lulas B grandes en estadio IV (LDCBG), una forma invasora de linfoma no hodgkiniano. \u00abEs lo m\u00e1s atemorizante\u00bb, dijo. Tras tratarse con una inmunoterapia de eliminaci\u00f3n de linfocitos B llamada rituximab (Rituxan\u00ae) combinada con quimioterapia y un trasplante de c\u00e9lulas madre, Michael est\u00e1 sin c\u00e1ncer. Este financiero de 46 a\u00f1os cuenta que su experiencia con la enfermedad lo llev\u00f3 a \u00abun despertar\u00bb: no solo lo inspir\u00f3 a priorizar su relaci\u00f3n con su esposa y su familia, sino que tambi\u00e9n le despert\u00f3 una sed de aventuras.<\/p>\n\n\n\n<p>TheAnswertoCancer (TheA2C) habl\u00f3 con Michael sobre su lucha contra el c\u00e1ncer y sus nuevos pasatiempos de aventuras.<\/p>\n\n\n\n<h2 class=\"wp-block-heading\">Preguntas y respuestas<\/h2>\n\n\n\n\n<p>En febrero de 2008 descubr\u00ed que ten\u00eda linfoma. Empec\u00e9 a sentirme no del todo normal en noviembre de 2007. Sab\u00eda que algo andaba mal porque sent\u00eda cansancio y adelgazaba con bastante rapidez. Fui al m\u00e9dico en diciembre de 2007 y comenzaron a hacerme varios estudios para tratar de determinar qu\u00e9 pod\u00eda ser. Hab\u00eda un tiempo de espera de entre 30 y 45 d\u00edas, y le dije al m\u00e9dico que me llamara cuando tuviera el diagn\u00f3stico porque quer\u00eda saberlo lo antes posible. De hecho, estaba en el trabajo cuando me enter\u00e9, lo que fue un poco extra\u00f1o. Por supuesto que llam\u00e9 a mi esposa de inmediato y luego a mi jefe, que tambi\u00e9n sab\u00eda que algo andaba mal. No me ve\u00eda ni me sent\u00eda para nada bien.<\/p>\n\n\n\n\n\n<p>Por suerte, para este tipo espec\u00edfico de c\u00e1ncer hab\u00eda un tratamiento bastante corriente denominado R-CHOP: la \u00abR\u00bb es de Rituxan y las otras letras representan otros cuatro f\u00e1rmacos de quimioterapia. Hablamos de hacer seis series de quimioterapia R-CHOP y luego, despu\u00e9s de tres o cuatro tratamientos, me har\u00edan una exploraci\u00f3n PET para ver si la enfermedad se hab\u00eda frenado o parec\u00eda encaminarse a la remisi\u00f3n.<\/p>\n\n\n\n\n\n<p>Con este tipo de linfoma los tratamientos son cada tres semanas, y entre el primer y el segundo tratamiento fue bastante dif\u00edcil. Al principio tuve la t\u00edpica respuesta a la quimioterapia intensiva, me sent\u00eda cansado, ten\u00eda sensaci\u00f3n de malestar y muchas otras molestias f\u00edsicas. Con la segunda y la tercera ronda, creo que el tratamiento empez\u00f3 a surtir efecto y comenc\u00e9 a sentirme un poco mejor. De hecho, volv\u00ed a trabajar despu\u00e9s del cuarto tratamiento. Me sent\u00eda cada vez mejor e iban disminuyendo los efectos secundarios relacionados con los f\u00e1rmacos de quimioterapia y el Rituxan.<\/p>\n\n\n\n\n\n<p>Conc\u00e9ntrense siempre en un objetivo y lo conseguir\u00e1n. El objetivo final para m\u00ed era volver a tener una vida normal y luego tratar de hacer algunas cosas que no hab\u00eda hecho. Algunas de las cosas que hicimos en los \u00faltimos cuatro a\u00f1os, creo que posiblemente nunca hubiera considerado hacerlas de no haber pasado por todo esto.<\/p>\n\n\n\n\n<p><a href=\"https:\/\/www.cancerresearch.org\/es\"><\/a><\/p>\n","protected":false},"excerpt":{"rendered":"<p>Linfoma\u00a0| 2008 Algunas de las cosas que hicimos en los \u00faltimos cuatro a\u00f1os, creo que posiblemente nunca hubiera considerado hacerlas de no haber pasado por todo esto. La historia de Michael En [&hellip;]<\/p>\n","protected":false},"author":22,"featured_media":21931,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"_acf_changed":false,"inline_featured_image":false,"footnotes":""},"categories":[678],"tags":[695,439],"resource_cancer_types":[],"resource_patient_age":[],"resource_cancer_stage":[],"resource_treatment_type":[],"resource_treatment_status":[],"class_list":["post-26226","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-patient-story-es","tag-lymphoma-es","tag-patient-stories-es"],"acf":[],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v26.8 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>Michael R&#039;s Immunotherapy Story - Cancer Research Institute<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.cancerresearch.org\/blog\/michael-r\" \/>\n<meta property=\"og:locale\" content=\"es_ES\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Michael R&#039;s Immunotherapy Story - Cancer Research Institute\" \/>\n<meta property=\"og:description\" content=\"Linfoma\u00a0| 2008 Algunas de las cosas que hicimos en los \u00faltimos cuatro a\u00f1os, creo que posiblemente nunca hubiera considerado hacerlas de no haber pasado por todo esto. La historia de Michael En [&hellip;]\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.cancerresearch.org\/blog\/michael-r\" \/>\n<meta property=\"og:site_name\" content=\"Cancer Research Institute\" \/>\n<meta property=\"article:published_time\" content=\"2017-03-15T05:14:00+00:00\" \/>\n<meta property=\"article:modified_time\" content=\"2022-10-14T20:40:38+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/www.cancerresearch.org\/wp-content\/uploads\/2022\/07\/ALT_michaelR_1_620x358.jpg\" \/>\n\t<meta property=\"og:image:width\" content=\"620\" \/>\n\t<meta property=\"og:image:height\" content=\"358\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/jpeg\" \/>\n<meta name=\"author\" content=\"CRI Staff\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Escrito por\" \/>\n\t<meta name=\"twitter:data1\" content=\"CRI Staff\" \/>\n\t<meta name=\"twitter:label2\" content=\"Tiempo de lectura\" \/>\n\t<meta name=\"twitter:data2\" content=\"3 minutos\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\/\/www.cancerresearch.org\/blog\/michael-r#article\",\"isPartOf\":{\"@id\":\"https:\/\/www.cancerresearch.org\/blog\/michael-r\"},\"author\":{\"name\":\"CRI Staff\",\"@id\":\"https:\/\/www.cancerresearch.org\/#\/schema\/person\/680495be68bab0b66f6ed175092684d4\"},\"headline\":\"Michael R&#8217;s Immunotherapy Story\",\"datePublished\":\"2017-03-15T05:14:00+00:00\",\"dateModified\":\"2022-10-14T20:40:38+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\/\/www.cancerresearch.org\/blog\/michael-r\"},\"wordCount\":534,\"publisher\":{\"@id\":\"https:\/\/www.cancerresearch.org\/#organization\"},\"image\":{\"@id\":\"https:\/\/www.cancerresearch.org\/blog\/michael-r#primaryimage\"},\"thumbnailUrl\":\"https:\/\/www.cancerresearch.org\/wp-content\/uploads\/2022\/07\/ALT_michaelR_1_620x358.jpg\",\"keywords\":[\"lymphoma\",\"patient stories\"],\"articleSection\":[\"Patient Story\"],\"inLanguage\":\"es\"},{\"@type\":\"WebPage\",\"@id\":\"https:\/\/www.cancerresearch.org\/blog\/michael-r\",\"url\":\"https:\/\/www.cancerresearch.org\/blog\/michael-r\",\"name\":\"Michael R's Immunotherapy Story - Cancer Research Institute\",\"isPartOf\":{\"@id\":\"https:\/\/www.cancerresearch.org\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\/\/www.cancerresearch.org\/blog\/michael-r#primaryimage\"},\"image\":{\"@id\":\"https:\/\/www.cancerresearch.org\/blog\/michael-r#primaryimage\"},\"thumbnailUrl\":\"https:\/\/www.cancerresearch.org\/wp-content\/uploads\/2022\/07\/ALT_michaelR_1_620x358.jpg\",\"datePublished\":\"2017-03-15T05:14:00+00:00\",\"dateModified\":\"2022-10-14T20:40:38+00:00\",\"breadcrumb\":{\"@id\":\"https:\/\/www.cancerresearch.org\/blog\/michael-r#breadcrumb\"},\"inLanguage\":\"es\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/www.cancerresearch.org\/blog\/michael-r\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"es\",\"@id\":\"https:\/\/www.cancerresearch.org\/blog\/michael-r#primaryimage\",\"url\":\"https:\/\/www.cancerresearch.org\/wp-content\/uploads\/2022\/07\/ALT_michaelR_1_620x358.jpg\",\"contentUrl\":\"https:\/\/www.cancerresearch.org\/wp-content\/uploads\/2022\/07\/ALT_michaelR_1_620x358.jpg\",\"width\":620,\"height\":358,\"caption\":\"Michael R\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\/\/www.cancerresearch.org\/blog\/michael-r#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\/\/www.cancerresearch.org\/es\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Michael R&#8217;s Immunotherapy Story\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/www.cancerresearch.org\/#website\",\"url\":\"https:\/\/www.cancerresearch.org\/\",\"name\":\"Cancer Research Institute\",\"description\":\"For a World Immune to Cancer\",\"publisher\":{\"@id\":\"https:\/\/www.cancerresearch.org\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/www.cancerresearch.org\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"es\"},{\"@type\":\"Organization\",\"@id\":\"https:\/\/www.cancerresearch.org\/#organization\",\"name\":\"Cancer Research Institute\",\"url\":\"https:\/\/www.cancerresearch.org\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"es\",\"@id\":\"https:\/\/www.cancerresearch.org\/#\/schema\/logo\/image\/\",\"url\":\"https:\/\/www.cancerresearch.org\/wp-content\/uploads\/2025\/05\/logo-gradient.svg\",\"contentUrl\":\"https:\/\/www.cancerresearch.org\/wp-content\/uploads\/2025\/05\/logo-gradient.svg\",\"width\":156,\"height\":53,\"caption\":\"Cancer Research Institute\"},\"image\":{\"@id\":\"https:\/\/www.cancerresearch.org\/#\/schema\/logo\/image\/\"}},{\"@type\":\"Person\",\"@id\":\"https:\/\/www.cancerresearch.org\/#\/schema\/person\/680495be68bab0b66f6ed175092684d4\",\"name\":\"CRI Staff\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"es\",\"@id\":\"https:\/\/www.cancerresearch.org\/#\/schema\/person\/image\/\",\"url\":\"https:\/\/secure.gravatar.com\/avatar\/02f0ef777fed64d4eb97f93e70b904a9061fb107f8ea80db798cc9417248410f?s=96&d=mm&r=g\",\"contentUrl\":\"https:\/\/secure.gravatar.com\/avatar\/02f0ef777fed64d4eb97f93e70b904a9061fb107f8ea80db798cc9417248410f?s=96&d=mm&r=g\",\"caption\":\"CRI Staff\"},\"url\":\"https:\/\/www.cancerresearch.org\/es\/blog\/author\/cristaff\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Michael R's Immunotherapy Story - Cancer Research Institute","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.cancerresearch.org\/blog\/michael-r","og_locale":"es_ES","og_type":"article","og_title":"Michael R's Immunotherapy Story - Cancer Research Institute","og_description":"Linfoma\u00a0| 2008 Algunas de las cosas que hicimos en los \u00faltimos cuatro a\u00f1os, creo que posiblemente nunca hubiera considerado hacerlas de no haber pasado por todo esto. La historia de Michael En [&hellip;]","og_url":"https:\/\/www.cancerresearch.org\/blog\/michael-r","og_site_name":"Cancer Research Institute","article_published_time":"2017-03-15T05:14:00+00:00","article_modified_time":"2022-10-14T20:40:38+00:00","og_image":[{"width":620,"height":358,"url":"https:\/\/www.cancerresearch.org\/wp-content\/uploads\/2022\/07\/ALT_michaelR_1_620x358.jpg","type":"image\/jpeg"}],"author":"CRI Staff","twitter_card":"summary_large_image","twitter_misc":{"Escrito por":"CRI Staff","Tiempo de lectura":"3 minutos"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/www.cancerresearch.org\/blog\/michael-r#article","isPartOf":{"@id":"https:\/\/www.cancerresearch.org\/blog\/michael-r"},"author":{"name":"CRI Staff","@id":"https:\/\/www.cancerresearch.org\/#\/schema\/person\/680495be68bab0b66f6ed175092684d4"},"headline":"Michael R&#8217;s Immunotherapy Story","datePublished":"2017-03-15T05:14:00+00:00","dateModified":"2022-10-14T20:40:38+00:00","mainEntityOfPage":{"@id":"https:\/\/www.cancerresearch.org\/blog\/michael-r"},"wordCount":534,"publisher":{"@id":"https:\/\/www.cancerresearch.org\/#organization"},"image":{"@id":"https:\/\/www.cancerresearch.org\/blog\/michael-r#primaryimage"},"thumbnailUrl":"https:\/\/www.cancerresearch.org\/wp-content\/uploads\/2022\/07\/ALT_michaelR_1_620x358.jpg","keywords":["lymphoma","patient stories"],"articleSection":["Patient Story"],"inLanguage":"es"},{"@type":"WebPage","@id":"https:\/\/www.cancerresearch.org\/blog\/michael-r","url":"https:\/\/www.cancerresearch.org\/blog\/michael-r","name":"Michael R's Immunotherapy Story - Cancer Research Institute","isPartOf":{"@id":"https:\/\/www.cancerresearch.org\/#website"},"primaryImageOfPage":{"@id":"https:\/\/www.cancerresearch.org\/blog\/michael-r#primaryimage"},"image":{"@id":"https:\/\/www.cancerresearch.org\/blog\/michael-r#primaryimage"},"thumbnailUrl":"https:\/\/www.cancerresearch.org\/wp-content\/uploads\/2022\/07\/ALT_michaelR_1_620x358.jpg","datePublished":"2017-03-15T05:14:00+00:00","dateModified":"2022-10-14T20:40:38+00:00","breadcrumb":{"@id":"https:\/\/www.cancerresearch.org\/blog\/michael-r#breadcrumb"},"inLanguage":"es","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.cancerresearch.org\/blog\/michael-r"]}]},{"@type":"ImageObject","inLanguage":"es","@id":"https:\/\/www.cancerresearch.org\/blog\/michael-r#primaryimage","url":"https:\/\/www.cancerresearch.org\/wp-content\/uploads\/2022\/07\/ALT_michaelR_1_620x358.jpg","contentUrl":"https:\/\/www.cancerresearch.org\/wp-content\/uploads\/2022\/07\/ALT_michaelR_1_620x358.jpg","width":620,"height":358,"caption":"Michael R"},{"@type":"BreadcrumbList","@id":"https:\/\/www.cancerresearch.org\/blog\/michael-r#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/www.cancerresearch.org\/es"},{"@type":"ListItem","position":2,"name":"Michael R&#8217;s Immunotherapy Story"}]},{"@type":"WebSite","@id":"https:\/\/www.cancerresearch.org\/#website","url":"https:\/\/www.cancerresearch.org\/","name":"Cancer Research Institute","description":"For a World Immune to Cancer","publisher":{"@id":"https:\/\/www.cancerresearch.org\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.cancerresearch.org\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"es"},{"@type":"Organization","@id":"https:\/\/www.cancerresearch.org\/#organization","name":"Cancer Research Institute","url":"https:\/\/www.cancerresearch.org\/","logo":{"@type":"ImageObject","inLanguage":"es","@id":"https:\/\/www.cancerresearch.org\/#\/schema\/logo\/image\/","url":"https:\/\/www.cancerresearch.org\/wp-content\/uploads\/2025\/05\/logo-gradient.svg","contentUrl":"https:\/\/www.cancerresearch.org\/wp-content\/uploads\/2025\/05\/logo-gradient.svg","width":156,"height":53,"caption":"Cancer Research Institute"},"image":{"@id":"https:\/\/www.cancerresearch.org\/#\/schema\/logo\/image\/"}},{"@type":"Person","@id":"https:\/\/www.cancerresearch.org\/#\/schema\/person\/680495be68bab0b66f6ed175092684d4","name":"CRI Staff","image":{"@type":"ImageObject","inLanguage":"es","@id":"https:\/\/www.cancerresearch.org\/#\/schema\/person\/image\/","url":"https:\/\/secure.gravatar.com\/avatar\/02f0ef777fed64d4eb97f93e70b904a9061fb107f8ea80db798cc9417248410f?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/02f0ef777fed64d4eb97f93e70b904a9061fb107f8ea80db798cc9417248410f?s=96&d=mm&r=g","caption":"CRI Staff"},"url":"https:\/\/www.cancerresearch.org\/es\/blog\/author\/cristaff"}]}},"_links":{"self":[{"href":"https:\/\/www.cancerresearch.org\/es\/wp-json\/wp\/v2\/posts\/26226","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.cancerresearch.org\/es\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.cancerresearch.org\/es\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.cancerresearch.org\/es\/wp-json\/wp\/v2\/users\/22"}],"replies":[{"embeddable":true,"href":"https:\/\/www.cancerresearch.org\/es\/wp-json\/wp\/v2\/comments?post=26226"}],"version-history":[{"count":0,"href":"https:\/\/www.cancerresearch.org\/es\/wp-json\/wp\/v2\/posts\/26226\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/www.cancerresearch.org\/es\/wp-json\/wp\/v2\/media\/21931"}],"wp:attachment":[{"href":"https:\/\/www.cancerresearch.org\/es\/wp-json\/wp\/v2\/media?parent=26226"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.cancerresearch.org\/es\/wp-json\/wp\/v2\/categories?post=26226"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.cancerresearch.org\/es\/wp-json\/wp\/v2\/tags?post=26226"},{"taxonomy":"resource_cancer_types","embeddable":true,"href":"https:\/\/www.cancerresearch.org\/es\/wp-json\/wp\/v2\/resource_cancer_types?post=26226"},{"taxonomy":"resource_patient_age","embeddable":true,"href":"https:\/\/www.cancerresearch.org\/es\/wp-json\/wp\/v2\/resource_patient_age?post=26226"},{"taxonomy":"resource_cancer_stage","embeddable":true,"href":"https:\/\/www.cancerresearch.org\/es\/wp-json\/wp\/v2\/resource_cancer_stage?post=26226"},{"taxonomy":"resource_treatment_type","embeddable":true,"href":"https:\/\/www.cancerresearch.org\/es\/wp-json\/wp\/v2\/resource_treatment_type?post=26226"},{"taxonomy":"resource_treatment_status","embeddable":true,"href":"https:\/\/www.cancerresearch.org\/es\/wp-json\/wp\/v2\/resource_treatment_status?post=26226"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}